Himal Lal - Concepedia

Author

Himal Lal

GlaxoSmithKline (Belgium)ORCID

Also Known As

H. Lal, Himal Lal, Ige A George

Publications

3.6K

Citations

H-Index

Concepts

All Affiliations

GlaxoSmithKline (Belgium)University of Defence GlaxoSmithKline (United States)The University of Sydney University of Colorado Anschutz Medical Campus

About

Himal Lal is an author at GlaxoSmithKline (Belgium) specializing in precision vaccinology, medicine, and vaccinology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	81
2	Epidemiology	1	1	47
3	Immunology	1	1	34
4	Clinical Epidemiology	1	1	34
5	Clinical Trials	1	1	47

Himal Lal

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults Himal Lal, Anthony L. Cunningham, Olivier Godeaux, New England Journal of Medicine	2015	1.4K
Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older Anthony L. Cunningham, Himal Lal, Martina Kovac, New England Journal of Medicine	2016	1K
Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older Anthony L. Cunningham, Thomas C. Heineman, Himal Lal, The Journal of Infectious Diseases	2018	185
Pivotal Phase 3 Randomized Clinical Trial of the Safety, Tolerability, and Immunogenicity of 20-Valent Pneumococcal Conjugate Vaccine in Adults Aged ≥18 Years Brandon Essink, Charu Sabharwal, Kevin Cannon, Clinical Infectious Diseases	2021	154
Long-term immunogenicity and safety of an investigational herpes zoster subunit vaccine in older adults Roman Chlíbek, Karlis Pauksens, Lars Rombo, Vaccine	2015	121
Persistence of immune response to an adjuvanted varicella-zoster virus subunit vaccine for up to year nine in older adults Tino F. Schwarz, Stéphanie Volpe, Grégory Catteau, Human Vaccines & Immunotherapeutics	2018	78
Immunogenicity and Safety of an Adjuvanted Herpes Zoster Subunit Vaccine Coadministered With Seasonal Influenza Vaccine in Adults Aged 50 Years or Older Tino F. Schwarz, Naresh Aggarwal, Beate Moeckesch, The Journal of Infectious Diseases	2017	76
Immunogenicity and Safety of the HZ/su Adjuvanted Herpes Zoster Subunit Vaccine in Adults Previously Vaccinated With a Live Attenuated Herpes Zoster Vaccine Katrijn Grupping, Laura Cámpora, Martine Douha, The Journal of Infectious Diseases	2017	72
Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials Marta López‐Fauqued, Laura Cámpora, Frédérique Delannois, Vaccine	2019	61
Quality of Life Impact of an Adjuvanted Recombinant Zoster Vaccine in Adults Aged 50 Years and Older Desmond Curran, Lidia Oostvogels, Thomas C. Heineman, The Journals of Gerontology Series A	2018	56

Page 1